Early effects of Vaccine Immunisation (EVI) study
Latest Information Update: 10 Aug 2021
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Human papillomavirus infections
- Focus Pharmacodynamics
- Acronyms EVI study
- 10 Aug 2021 New trial record